AMCP submitted comments on a Office of Management and Budget request for information on advancing equity in underserved communities through government.
This AMCP and AMCP Foundation webinar reviewed the complexities of real-world evidence and its increasingly important role in health care decision-making.
Traditionally, treatment for chronic conditions addressed symptoms or was disease modifying and required lifelong periodic administration and recurring costs. This research extends a previous study by analyzing member retention for adult patients with certain rare diseases.
As an increasing number of orphan drugs are FDA approved, health care payers, employers, and providers are attempting to strike a balance between patient access to innovative treatments and overall affordability.
